Trial will test stem cells as cerebral palsy treatment

02/12/2010 | Disability Scoop

Researchers at the Medical College of Georgia are preparing to start the first FDA-approved clinical study of the effectiveness of using umbilical cord-blood stem cells as treatment for cerebral palsy. The trial will involve 40 patients ages 2 to 12. Doctors will examine the patients for improvements three months, six months and nine months into the trial.

View Full Article in:

Disability Scoop

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD